Clinical Trials on Glabellar Crease
Total 10000 results
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Active, not recruitingTriple-negative Breast Cancer and HR+/HER2- BCChina
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage IIIUnited States
-
Institut Claudius RegaudCompletedTriple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mmFrance
-
City of Hope Medical CenterNational Cancer Institute (NCI); Biopharmaceutical Research CompanyRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Breast Ductal Carcinoma In Situ | Breast Adenocarcinoma | Estrogen Receptor-Positive Breast Carcinoma | Progesterone Receptor-Positive...United States
-
National Taiwan University HospitalRecruitingEarly Breast Cancer | Ductal Breast Carcinoma In SituTaiwan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)SuspendedAnatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma | Anatomic Stage 1 Breast Cancer AJCC v8 | Estrogen Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Adult Solid NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Hormone Receptor-Positive Breast Carcinoma | Unresectable Hormone Receptor-Positive Breast Carcinoma | Advanced Hormone Receptor-Positive Breast CarcinomaUnited States
-
KK Women's and Children's HospitalRecruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)Singapore
-
Margaret Gatti-MaysRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | HER2-Negative Breast CarcinomaUnited States
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Indonesia UniversityRecruitingTriple Negative Breast Cancer | Chemotherapy Effect | Simvastatin Adverse ReactionIndonesia
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression HighMalaysia
-
Celldex TherapeuticsNo longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Italy, France
-
Massachusetts General HospitalNational Cancer Institute (NCI); American Society of Clinical OncologyActive, not recruitingMyocardial Fibrosis | Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage IIIUnited States
-
Jonsson Comprehensive Cancer CenterCompletedCancer Survivor | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage 0 Breast Cancer AJCC...United States
-
Yuan YuanOsel, Inc.; Miyarisan Pharmaceuticals, Co., Ltd.Not yet recruitingTNBC - Triple-Negative Breast Cancer | TNBC | Early Stage Triple-Negative Breast CarcinomaUnited States
-
Fujian Cancer HospitalNot yet recruitingEarly Breast Cancer | Adjuvant Therapy | Hormone Receptor Positive / HER2-negative Breast Cancer
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdRecruitingInoperable Locally Advanced HER2-Negative Breast Cancer | Metastatic HER2-Negative Breast CancerChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingTriple Negative Breast CancerUnited States
-
West German Study GroupMerck Sharp & Dohme LLC; Gilead SciencesRecruitingTriple Negative Breast CancerGermany
-
Daiichi SankyoActive, not recruitingTriple Negative Breast CancerUnited States
-
University of AlbertaActive, not recruitingBreast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3)Canada
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupTerminatedStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Yale UniversityNational Cancer Institute (NCI)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast CarcinomaUnited States
-
Batterjee Medical CollegeCompletedBreast Cancer Early Stage Breast Cancer (Stage 1-3)Egypt
-
Ziauddin UniversityJinnah Sindh Medical UniversityCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer | Neoadjuvant Therapy | Hormone Receptor-positive Breast Cancer | HER2-low-expressing Breast CancerChina
-
Institut Cancerologie de l'OuestSIRIC ILIADCompletedTriple Negative Breast CancerFrance
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
Merck Sharp & Dohme LLCCompleted
-
GTxTerminatedTriple Negative Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer Female | Survivorship | Early-stage Breast Cancer | Cancer Survivors | Transitional CareUnited States
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
Xiaoming XieUnknown
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedPain | Peripheral Neuropathy | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Chemotherapeutic Agent Toxicity | Therapy-related ToxicityUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
Tang-Du HospitalNot yet recruitingBreast Cancer | HR Positive/HER2 Low Breast Cancer
-
Fudan UniversityNot yet recruitingTriple -Negative Breast CancerChina
-
Washington University School of MedicineNot yet recruitingTriple Negative Breast CancerUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Breast Cancer
-
West China HospitalNot yet recruiting
-
Fudan UniversityRecruitingHER2-positive Breast CancerChina
-
Washington University School of MedicineRecruitingBreast Cancer | Cancer of the BreastUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruiting
-
Henan Cancer HospitalRecruitingBreast Cancer | HR+/HER2- Breast CancerChina
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
M.D. Anderson Cancer CenterRecruiting